Lawrence Otto Klein Crispr Therapeutics Ag (CRSP) insider trading activity
Lawrence Otto Klein is CBO & COO of CRISPR Therapeutics AG. Currently has a direct ownership of 26,797 shares of CRSP, which is worth approximately $1.21 Million. The most recent transaction as insider was on Jan 02, 2019, when has been sold 20,000 shares (Restricted Stock Units) at a price of $29.87 per share, resulting in proceeds of $597,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
26.8K
0%
3M change
0%
12M change
Total Value Held
$1.21 Million
Lawrence Otto Klein Transaction History
Also insider at
LOK
Lawrence Otto Klein
CBO & COO
Cambridge, MA